Weekly Cyclophosphamide and Alternate-Day Prednisone: An Effective, Convenient, and Well-Tolerated Oral Treatment for Relapsed Multiple Myeloma After Autologous Stem Cell Transplantation
- 31 December 2005
- journal article
- Published by Elsevier BV in Mayo Clinic Proceedings
- Vol. 80 (12), 1578-1582
- https://doi.org/10.4065/80.12.1578
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Phase II Trial of Single Agent Bortezomib (VELCADE®) in Patients with Previously Untreated Multiple Myeloma (MM).Blood, 2004
- High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple MyelomaThe New England Journal of Medicine, 2003
- The Role of High-Dose Chemotherapy and Stem-Cell Transplantation in Patients with Multiple Myeloma: A Practice Guideline of the Cancer Care Ontario Practice Guidelines InitiativeAnnals of Internal Medicine, 2002
- Continuous low-dose cyclophosphamide–prednisone is effective and well tolerated in patients with advanced multiple myelomaStroke Prevention in Atrial Fibrillation, 2001
- CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATIONBritish Journal of Haematology, 1998
- A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple MyelomaThe New England Journal of Medicine, 1996
- An Aggressive High Dose Cyclophosphamide and Prednisone Regimen for Advanced Multiple MyelomaLeukemia & Lymphoma, 1994
- High-dose cyclophosphamide. An effective treatment for advanced refractory multiple myelomaCancer, 1984
- Factors Responsible for Bone Marrow Toxicity after Treatment of Myeloma Patients with Different Alkylating AgentsActa Medica Scandinavica, 1978
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958